Skip to main content
. 2016 Jun 30;2016:5325762. doi: 10.1155/2016/5325762

Figure 1.

Figure 1

Metastasis-free survival (MFS) rates for CLEAR registry patients. Kaplan-Meier analysis of MFS for 70 patients enrolled in the CLEAR uveal melanoma study. Class 1 patients had a 3-year MFS rate of 100% versus 63% for Class 2 patients; the median rate of metastasis was 3.78 years for Class 2 patients but not reached for Class 1 patients.